Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Clin Cancer Res. 2019 Aug 22;25(21):6302–6308. doi: 10.1158/1078-0432.CCR-19-0986

Table 3:

Growth, FDG-PET, and tumor density evaluation.

Patient number Time to progression (months) Growth modulation index Pretreatment FDG-PET SUVmax Day 3–6 FDG-PET SUVmax Pre-cycle 4 FDG-PET SUVmax Pretreatment Mean Density (HU) First Restaging Mean Density (HU)
1 2.7 .63 30.7 19.3 11.5 36.1 49.8
2 22.4 1.3 15.6 7.5 8.9 103.1 122.4
3 2 1.3 16.2 NP NP 64.6 54.7
4 NA NA 21.4 NP 21.4 109.5 105.0
5 5 .28 17.9 10.5 19.3 122.4 115.1
6 2.8 .82 11.6 NP 13.8 102.2 98.8
7 NA NA 25.3 NP 31.4 79.6 71.7
8 4.3 .93 24.4 22.0 17.8 63.6 64.2
9 NA NA 25.3 NP 27.4 90.4 89.1

Abbreviations: FDG-PET=18-Fluoro-deoxyglucose positron emission tomography ; SUVmax = maximum standardized uptake value; HU=Hounsfield units; NA=not available; NP=not performed